Rsv vaccine

CR20260067APending Publication Date: 2026-05-20ASTRAZENECA AB
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CR · CR
Patent Type
Applications
Current Assignee / Owner
ASTRAZENECA AB
Filing Date
2024-07-18
Publication Date
2026-05-20
Patent Text Reader

Abstract

A vaccine against RSV is provided herein. The vaccine comprises an mRNA encoding a stabilized RSV prefusion F protein immunogen, linked to a lumazine synthase-based scaffold.
Need to check novelty before this filing date? Find Prior Art